Effect of Dermaseptin S4 on C. albicans Growth and EAP1 and HWP1 Gene Expression
- 21 July 2020
- journal article
- research article
- Published by Springer Nature in Probiotics and Antimicrobial Proteins
- Vol. 13 (1) , 287-298
Abstract
Increasing resistance and changes in the spectrum of Candida infections have generated considerable interest in the development of new antifungal molecules. The use of antimicrobial peptides (AMPs) appears to be a promising approach. Frog skin AMPs (such as dermaseptins) have shown antimicrobial activity against several pathogens. In this study, we aimed to test the antimicrobial efficacy of dermaseptin S4 (DS4) against C. albicans. We determined the minimal inhibitory concentration (MIC) of DS4, and investigated the effects of the DS4 at low concentrations on human primary gingival fibroblasts. Additionally, we evaluated the effect of DS4 on C. albicans growth, form changes, and biofilm formation, as well as the expression of certain virulent genes. Our data show that DS4 completely inhibits C. albicans growth at a concentration of 32 μg/mL referring to the MIC of DS4. It should be noted that even with low concentrations (below 16 μg/mL), DS4 still have significant growth reduction of C. albicans, but were not toxic to human gingival fibroblasts. DS4 inhibited the transition from yeast to hyphae, and decreased the biofilm formation by reducing the biofilm mass weight. Surface morphological changes in the yeast cell membrane were observed following exposure to DS4. The gene expression analyses revealed that DS4 significantly decreased the expression of EAP1 and HWP1 genes. Overall results suggest the potential use of DS4 as an antifungal therapy to prevent C. albicans pathogenesis.Keywords
This publication has 47 references indexed in Scilit:
- C. albicansgrowth, transition, biofilm formation, and gene expression modulation by antimicrobial decapeptide KSL-WBMC Microbiology, 2013
- Candida albicanspathogenicity mechanismsVirulence, 2013
- Loss of mannosylphosphate from Candida albicans cell wall proteins results in enhanced resistance to the inhibitory effect of a cationic antimicrobial peptide via reduced peptide binding to the cell surfaceMicrobiology, 2009
- Candida albicansCell Wall ProteinsMicrobiology and Molecular Biology Reviews, 2008
- Activity of an Antimicrobial Peptide Mimetic against Planktonic and Biofilm Cultures of Oral PathogensAntimicrobial Agents and Chemotherapy, 2007
- Eap1p, an Adhesin That Mediates Candida albicans Biofilm Formation In Vitro and In VivoEukaryotic Cell, 2007
- Acyl-Substituted Dermaseptin S4 Derivatives with Improved Bactericidal Properties, Including on Oral MicrofloraAntimicrobial Agents and Chemotherapy, 2006
- Function of Candida albicans Adhesin Hwp1 in Biofilm FormationEukaryotic Cell, 2006
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Isolation and structure of novel defensive peptides from frog skinEuropean Journal of Biochemistry, 1994